Xylem (XYL) Given a $57.00 Price Target at Berenberg Bank

Berenberg Bank set a $57.00 target price on Xylem (NYSE:XYL) in a research note issued to investors on Thursday morning. The brokerage currently has a sell rating on the industrial products company’s stock.

Several other equities research analysts have also recently weighed in on the company. Vertical Research cut Xylem from a hold rating to a sell rating in a research report on Monday, October 8th. Canaccord Genuity set a $78.00 price objective on Xylem and gave the company a hold rating in a research report on Tuesday, July 24th. Credit Suisse Group started coverage on Xylem in a research report on Friday, October 12th. They issued an outperform rating and a $86.00 price objective for the company. Raymond James started coverage on Xylem in a research report on Wednesday, September 5th. They issued an outperform rating and a $90.00 price objective for the company. Finally, Robert W. Baird reissued a hold rating and issued a $80.00 price objective on shares of Xylem in a research report on Wednesday, August 1st. One analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the company. The company has a consensus rating of Buy and an average price target of $80.50.

Xylem stock traded down $0.33 during trading hours on Thursday, reaching $66.52. 1,195,568 shares of the company were exchanged, compared to its average volume of 1,102,141. The stock has a market capitalization of $12.46 billion, a P/E ratio of 27.72, a PEG ratio of 1.33 and a beta of 1.22. The company has a quick ratio of 1.02, a current ratio of 1.43 and a debt-to-equity ratio of 0.86. Xylem has a 12 month low of $64.33 and a 12 month high of $82.44.



Xylem (NYSE:XYL) last announced its earnings results on Tuesday, July 31st. The industrial products company reported $0.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.02. The firm had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.28 billion. Xylem had a return on equity of 19.04% and a net margin of 7.39%. The company’s revenue was up 13.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.59 earnings per share. Sell-side analysts anticipate that Xylem will post 2.9 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 7th. Investors of record on Thursday, November 1st will be paid a $0.21 dividend. The ex-dividend date of this dividend is Wednesday, October 31st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.26%. Xylem’s payout ratio is 35.00%.

In related news, insider Colin R. Sabol sold 17,161 shares of the company’s stock in a transaction on Monday, September 17th. The stock was sold at an average price of $81.37, for a total value of $1,396,390.57. Following the completion of the transaction, the insider now directly owns 41,988 shares in the company, valued at $3,416,563.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Kairus Tarapore sold 18,800 shares of the company’s stock in a transaction on Friday, August 3rd. The shares were sold at an average price of $75.17, for a total value of $1,413,196.00. Following the completion of the transaction, the senior vice president now owns 31,580 shares of the company’s stock, valued at $2,373,868.60. The disclosure for this sale can be found here. Insiders sold 49,284 shares of company stock valued at $3,839,982 over the last 90 days. 0.81% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Congress Asset Management Co. MA raised its stake in Xylem by 4,780.9% during the second quarter. Congress Asset Management Co. MA now owns 1,112,856 shares of the industrial products company’s stock worth $74,984,000 after acquiring an additional 1,090,056 shares in the last quarter. Janus Henderson Group PLC raised its stake in Xylem by 38.1% during the second quarter. Janus Henderson Group PLC now owns 3,189,273 shares of the industrial products company’s stock worth $214,898,000 after acquiring an additional 880,125 shares in the last quarter. USS Investment Management Ltd raised its stake in Xylem by 43.7% during the second quarter. USS Investment Management Ltd now owns 2,615,320 shares of the industrial products company’s stock worth $176,220,000 after acquiring an additional 795,628 shares in the last quarter. Renaissance Technologies LLC raised its stake in Xylem by 553.1% during the second quarter. Renaissance Technologies LLC now owns 442,800 shares of the industrial products company’s stock worth $29,836,000 after acquiring an additional 375,000 shares in the last quarter. Finally, Morgan Stanley raised its stake in Xylem by 43.1% during the second quarter. Morgan Stanley now owns 1,175,977 shares of the industrial products company’s stock worth $79,238,000 after acquiring an additional 354,340 shares in the last quarter. Institutional investors and hedge funds own 84.60% of the company’s stock.

About Xylem

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Read More: Is the Dow Jones Industrial Average (DJIA) still relevant?

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply